Elevance Health, Inc. (ELV) Shareholders & Insider Trades

Executive TeamFinancialsSegmentsShareholders

Elevance Health shareholders at a glance

The largest holder of Elevance Health stock is Vanguard Capital Management LLC, with 14.1 million shares (6.48% of the company), worth about $5.52 billion as of September 25, 2026. The 10 largest holders together own 36.4%.

In Q2 2026, 1,690 institutional holdings reports listed shares worth $78.90 billion.

Insiders reported 59 transactions in the last two years: 9 sales worth $8.47 million and 6 purchases. The newest one on file is from July 17, 2026 (Peru Ramiro G, Director).

Major holders as of September 25, 2026; quarterly totals from institutional holdings reports (latest Q2 2026); insider transactions on file through July 17, 2026.

ELV logo

Elevance Health, Inc.

ELVUnited States
Healthcare

Shareholders Summary

2026Q2

Filings
1690
Options Value
$807.00M
Value (excl. Options)
$78.90B
Shares (excl. Options)
-

Ownership by Type

Geographic Distribution

Largest Elevance Health shareholders

HolderShares% of companyValue
Vanguard Capital Management LLC14.1 million6.48%$5.5B
BlackRock Advisors LLC13.6 million6.27%$5.3B
State Street Corporation10.4 million4.81%$4.1B
Wellington Trust Co., NA9.2 million4.25%$3.6B
Vanguard Portfolio Management LLC6.2 million2.87%$2.4B
Sanders Capital LLC5.8 million2.69%$2.3B
Geode Capital Management LLC5.2 million2.38%$2.0B
BlackRock Life Ltd.5.0 million2.32%$2.0B
Harris Associates LP4.9 million2.27%$1.9B
Artisan Partners Holdings LP4.6 million2.11%$1.8B

As of September 25, 2026.

Elevance Health institutional holdings by quarter

QuarterReportsSharesValue
Q2 20261,690–$78.9B
Q1 20261,533195.0 million$57.0B
Q4 20251,628203.0 million$71.2B
Q3 20251,603198.0 million$63.9B
Q2 20251,685207.0 million$80.2B
Q1 20251,752205.0 million$89.0B
Q4 20241,693208.0 million$76.6B
Q3 20241,785211.0 million$109.0B

Shares and value held by institutions that file quarterly holdings reports (options not included).

Elevance Health insider trades

InsiderDateTitleTransactionValue
Peru Ramiro GJul 17, 2026DirectorPurchase at price 366.05 per share.$366,050
Boudreaux Gail A KoziaraJul 17, 2026Chief Executive OfficerPurchase at price 366.41 - 368.25 per share.$1.0M
Penczek Ronald WJun 12, 2026OfficerSale at price 403.16 per share.$148,766
Dixon Robert L JrJun 11, 2026DirectorSale at price 401.77 per share.$60,667
Penczek Ronald WMay 19, 2026OfficerSale at price 403.13 per share.$617,192
Penczek Ronald WMay 19, 2026OfficerConversion of Exercise of derivative security at price 271.27 - 311.48 per share.$450,579
Strable-Soethout Deanna DMay 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Schulman Amy W.May 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Dixon Robert L JrMay 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Devore Susan DMay 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Neri Antonio FMay 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–
Schneider Ryan M.May 13, 2026DirectorStock Award(Grant) at price 0.00 per share.–

Newest 12 of 59 insider transactions in the last two years.

Questions and answers

Who owns the most Elevance Health stock?

Vanguard Capital Management LLC, with 6.48% of the company (as of September 25, 2026). Next: BlackRock Advisors LLC (6.27%) and State Street Corporation (4.81%).

How many institutions own Elevance Health stock?

1,690 institutional holdings reports listed Elevance Health shares in Q2 2026 worth $78.90 billion.

Are Elevance Health insiders buying or selling the stock?

In the last two years insiders reported 9 sales and 6 purchases (59 transactions in all); the newest on file is from July 17, 2026.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube